{
    "Clinical Trial ID": "NCT00843167",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Sulforaphane Supplement",
        "  Patients receive oral broccoli sprout extract supplementation three times daily for 2-8 weeks in the absence of unacceptable toxicity.",
        "  broccoli sprout extract: Given orally",
        "INTERVENTION 2: ",
        "  Placebo",
        "  Patients receive oral placebo supplementation three times daily for 2-8 weeks in the absence of unacceptable toxicity.",
        "  placebo: Given orally"
    ],
    "Eligibility": [
        "INCLUSION CRITERIA:",
        "  Diagnostic mammogram",
        "  English speaking",
        "EXCLUSION CRITERIA:",
        "  Pregnancy (as determined by urine human chorionic gonadotropin (hCG) test)",
        "  No biopsy referral after diagnostic mammogram",
        "  Patient reported breast feeding",
        "  Significant active medical illness which in the opinion of the investigator would preclude protocol treatment",
        "  History of or active liver disease or baseline total bilirubin greater than institutional upper limit of normal",
        "  Patient reported allergy or sensitivity to cruciferous vegetables",
        "  Use of oral antibiotics within three months prior to randomization",
        "  Oral steroid therapy at enrollment",
        "  Current therapy with valproate acid or SAHA",
        "  Current use of nutrient supplements or herbal remedies containing sulforaphane and unwillingness or inability to quit 72 hours prior to randomization and for the duration of the trial",
        "  Radiation for currently-diagnosed disease prior to or during study supplementation",
        "  Chemotherapy for currently-diagnosed disease prior to or during study supplementation"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Change in Isothiocyanate in Urine Samples as Assessed at Baseline and After Completion of Study Therapy",
        "  Isothiocyante including sulforaphane in micromolar (\u00b5M) concentration was measured following standard chemical measurement procedures and divided by the creatinine values in millimolar (mM) concentration.",
        "  Time frame: Baseline and end of study (up to 8 weeks)",
        "Results 1: ",
        "  Arm/Group Title: Sulforaphane Supplement",
        "  Arm/Group Description: Patients receive oral broccoli sprout extract supplementation three times daily for 2-8 weeks in the absence of unacceptable toxicity.",
        "  broccoli sprout extract: Given orally",
        "  Overall Number of Participants Analyzed: 27",
        "  Mean (Standard Error)",
        "  Unit of Measure:  M/mM creatinine  1.00         (0.334)",
        "Results 2: ",
        "  Arm/Group Title: Placebo",
        "  Arm/Group Description: Patients receive oral placebo supplementation three times daily for 2-8 weeks in the absence of unacceptable toxicity.",
        "  placebo: Given orally",
        "  Overall Number of Participants Analyzed: 27",
        "  Mean (Standard Error)",
        "  Unit of Measure:  M/mM creatinine  -0.05         (0.02)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/27 (0.00%)",
        "Adverse Events 2:",
        "  Total: 0/27 (0.00%)"
    ]
}